Skip to main content

Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market is Expected to Grow Drastically, Assured By Experts From 2023 To 2028

 


Surgical hemostat is a surgical tool used in many surgical procedures to control bleeding. Surgical hemostats covered in this report include thrombin-based, combination hemostats, oxidized regenerated cellulose-based, gelatin-based, and collagen-based. Internal tissue sealants are typically used in surgeries to bind or hold internal tissues such as blood vessels, internal organs, bone cartilage, dura matter and others.

The global surgical hemostats, internal tissue sealants and adhesion barriers market is estimated to account for US$ 4,231.4 Mn in terms of value in 2020 and is expected to reach US$ 7,346.7 Mn by the end of 2027

Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market: Drivers

Increasing number of surgical procedures is expected to propel growth of the global surgical hemostats, internal tissue sealants and adhesion barriers market over the forecast period. For instance, according to ‘Surgical operations and procedures statistics’ of Eurostat in November 2019, at least 1.4 million caesarean sections performed in the EU in 2017.

Moreover, high incidence of early postoperative small bowel obstruction is also expected to aid in growth of the market. For instance, according to the study, “Incidence and risk factors of early postoperative small bowel obstruction in patients undergoing hysterectomy for benign indications”, published in the American Journal of Obstetrics and Gynecology, in March 2019, the incidence rate of early small bowel obstructions was 5.9 per 1000 hysterectomies and 43.7% of the study population developed small bowel obstruction during the initial hospital stay and 23.1% underwent reoperation.

High number of cardiovascular procedures is expected to propel growth of the global surgical hemostats, internal tissue sealants and adhesion barriers market over the forecast period. For instance, according to American Heart Association 2019 Heart Disease and Stroke Statistics, 1,016,000 cardiac catheterizations and 3,244 heart transplants were performed in the U.S. in 2014 and 2017, respectively.      

Statistics:

Hemostat held dominant position in the global surgical hemostats, internal tissue sealants and adhesion barriers market in 2019, accounting for 41.1% share in terms of value, followed by Internal Tissue Sealants, and adhesion barriers respectively

 

Comments

Popular posts from this blog

The Global Pressure Bandages Market Is Witnessing High Growth Owing To the Increasing Incidence of Surgical Processes in the World

  Market Overview: During a medical emergency, a pressure bandage is used to apply pressure to an area of the body to control bleeding and swelling. There are a variety of types of pressure bandages that can be used for different purposes. The bandage is made up of several parts, including an air bladder, a pad, a closure bar, and an applicator. A pressure bandage can be applied to wounds at any location on the body. This type of dressing is useful in treating various conditions, including gunshot wounds. It can also be used for a temporary holding of a hernia. The bandage is usually vacuum-sealed, so it's easier to carry. Competitive Landscape: Major players operating in the global pressure bandages market include ConvaTec Group PLC., Cardinal Health, 3M, B. Braun Melsungen AG, Lohmann & Rauscher GmbH & Co. KG, Mölnlycke Health Care AB, Smith & Nephew plc., Paul Hartmann AG, and Essity (BSN medical GmbH). Key Market Drivers: Increasing developments by key pla...

Increasing Incidences of Infectious Diseases to Augment the Antibacterial Drugs Market Growth

  Antibacterial drugs are widely used to treat and prevent infectious diseases and are categorized into seven major classes, such as β-Lactams, phenicols, macrolides, quinolones, sulfonamides, tetracyclines, and aminoglycosides, based on their molecular structure. Antibacterial drugs destroy or slow down the growth of bacteria. These medications are also used to treat urinary infections caused by S. aureus, E. coli, Streptococcus pyogenes, and other bacterial infections. They include a range of powerful drugs used to treat diseases caused by bacteria. Antibiotics cannot treat viral infections, such as cold, flu, and most coughs. Antibacterial drugs play a major role in advanced healthcare, as they are widely used to treat infectious diseases, such as tuberculosis, malaria, typhoid, leprosy, hepatitis B, HIV/AIDS, and others. Thus, there is an increasing demand for antibacterial drugs worldwide.  

Immuno-oncology: Combination Therapies and Emerging Targets

  The study of and creation of therapies that use the immune system of the body to combat cancer are known as immuno-oncology. Our immune system, which is made up of a complex web of organs, cells, and molecules, guards us against external invaders like bacteria, fungus, and viruses that might infect us. The immune system is capable of locating and eliminating foreign objects as well as attacking aberrant cells. The immune system has the best chance of specifically destroying tumours without harming healthy tissue and having long-term memory that can stop cancer from coming back. The development of tumours can be permanently prevented or managed by a mechanism known as immunosurveillance, according to research in immuno-oncology conducted over the past 30 years. Recognition of tumour antigens is what gives the immune response its tumour specificity. The most well-established therapeutic class of IO drugs to date, immune checkpoint inhibitors have demonstrated significant effic...